BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11972106)

  • 1. Treatment of severe thrombocytopenia with IL-11 in children with Wiskott-Aldrich syndrome.
    Braithwaite K; Abu-Ghosh A; Anderson L; Cairo MS
    J Pediatr Hematol Oncol; 2002 May; 24(4):323-6. PubMed ID: 11972106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
    Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
    Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic peripheral blood stem cell transplantation in a Wiskott-Aldrich syndrome patient.
    Hongeng S; Pakakasama S; Hathirat P; Chaisiripoomkere W; Ungkanont A
    Bone Marrow Transplant; 1999 Aug; 24(4):445-6. PubMed ID: 10467341
    [No Abstract]   [Full Text] [Related]  

  • 4. Correction of persistent thrombocytopenia by a boost of CD133+ selected stem cells in a patient transplanted for Wiskott-Aldrich syndrome 10 years ago.
    Lang P; Klingebiel T; Schumm M; Handgretinger R; Greil J; Beck JF; Niethammer D; Bader P
    Bone Marrow Transplant; 2004 Apr; 33(8):879-80. PubMed ID: 14743191
    [No Abstract]   [Full Text] [Related]  

  • 5. Lentiviral gene therapy corrects platelet phenotype and function in patients with Wiskott-Aldrich syndrome.
    Sereni L; Castiello MC; Di Silvestre D; Della Valle P; Brombin C; Ferrua F; Cicalese MP; Pozzi L; Migliavacca M; Bernardo ME; Pignata C; Farah R; Notarangelo LD; Marcus N; Cattaneo L; Spinelli M; Giannelli S; Bosticardo M; van Rossem K; D'Angelo A; Aiuti A; Mauri P; Villa A
    J Allergy Clin Immunol; 2019 Sep; 144(3):825-838. PubMed ID: 30926529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and emerging treatment options for Wiskott-Aldrich syndrome.
    Worth AJ; Thrasher AJ
    Expert Rev Clin Immunol; 2015; 11(9):1015-32. PubMed ID: 26159751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenectomy in the management of the thrombocytopenia of the Wiskott-Aldrich syndrome.
    Lum LG; Tubergen DG; Corash L; Blaese RM
    N Engl J Med; 1980 Apr; 302(16):892-6. PubMed ID: 6767187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A unique presentation of Wiskott-Aldrich syndrome in relation to platelet size.
    Patel PD; Samanich JM; Mitchell WB; Manwani D
    Pediatr Blood Cancer; 2011 Jul; 56(7):1127-9. PubMed ID: 21488158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable mixed chimerism after hematopoietic stem cell transplantation in Wiskott-Aldrich syndrome.
    Doğu F; Kurtuluş-Ulküer M; Bilge Y; Bozdoğan G; Ulküer U; Malhatun E; Ikincioğullari A; Babacan E
    Pediatr Transplant; 2006 May; 10(3):395-9. PubMed ID: 16677369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome.
    Hacein-Bey Abina S; Gaspar HB; Blondeau J; Caccavelli L; Charrier S; Buckland K; Picard C; Six E; Himoudi N; Gilmour K; McNicol AM; Hara H; Xu-Bayford J; Rivat C; Touzot F; Mavilio F; Lim A; Treluyer JM; Héritier S; Lefrère F; Magalon J; Pengue-Koyi I; Honnet G; Blanche S; Sherman EA; Male F; Berry C; Malani N; Bushman FD; Fischer A; Thrasher AJ; Galy A; Cavazzana M
    JAMA; 2015 Apr; 313(15):1550-63. PubMed ID: 25898053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Persistent thrombocytopenia in a child: morphological examination of blood platelets established the diagnosis of Wiskott-Aldrich syndrome].
    Latger-Cannard V; Lacroix F; Devignes J; Salignac S; Bensoussan D; Salmon A; Mansuy L; Bordigoni P; Lecompte T
    Ann Biol Clin (Paris); 2008; 66(1):100-4. PubMed ID: 18227012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intravenous gammaglobulin (IVIG) on the platelet count in patients with Wiskott-Aldrich syndrome.
    Mathew P; Conley ME
    Pediatr Allergy Immunol; 1995 May; 6(2):91-4. PubMed ID: 7581726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multiinstitutional survey of the Wiskott-Aldrich syndrome.
    Sullivan KE; Mullen CA; Blaese RM; Winkelstein JA
    J Pediatr; 1994 Dec; 125(6 Pt 1):876-85. PubMed ID: 7996359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rare solid tumors in a patient with Wiskott-Aldrich syndrome after hematopoietic stem cell transplantation: case report and review of literature.
    Coppola E; Giardino G; Abate M; Tambaro FP; Bifano D; Toriello E; De Rosa A; Cillo F; Pignata C; Cirillo E
    Front Immunol; 2023; 14():1229674. PubMed ID: 37781361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wiskott-Aldrich syndrome: molecular pieces slide into place.
    Kuska B
    J Natl Cancer Inst; 2000 Jan; 92(1):9-11. PubMed ID: 10620622
    [No Abstract]   [Full Text] [Related]  

  • 16. Prophylactic platelet transfusion in children with thrombocytopenic disorders: a retrospective review.
    Ferrara M; Capozzi L; Coppola A; Save G; Coppola L
    Hematology; 2007 Aug; 12(4):297-9. PubMed ID: 17654055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome.
    Ngwube A; Hanson IC; Orange J; Rider NL; Seeborg F; Shearer W; Noroski L; Nicholas S; Forbes L; Leung K; Sasa G; Naik S; Hegde M; Omer B; Ahmed N; Allen C; Gottschalk S; Wu MF; Liu H; Brenner M; Heslop H; Krance R; Martinez C
    Biol Blood Marrow Transplant; 2018 Mar; 24(3):537-541. PubMed ID: 29196075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndrome.
    Shekhovtsova Z; Bonfim C; Ruggeri A; Nichele S; Page K; AlSeraihy A; Barriga F; de Toledo Codina JS; Veys P; Boelens JJ; Mellgren K; Bittencourt H; O'Brien T; Shaw PJ; Chybicka A; Volt F; Giannotti F; Gluckman E; Kurtzberg J; Gennery AR; Rocha V;
    Haematologica; 2017 Jun; 102(6):1112-1119. PubMed ID: 28255019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome and chimerism in patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation: a retrospective nationwide survey.
    Iguchi A; Cho Y; Yabe H; Kato S; Kato K; Hara J; Koh K; Takita J; Ishihara T; Inoue M; Imai K; Nakayama H; Hashii Y; Morimoto A; Atsuta Y; Morio T;
    Int J Hematol; 2019 Sep; 110(3):364-369. PubMed ID: 31187438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wiskott-Aldrich syndrome.
    Notarangelo LD; Miao CH; Ochs HD
    Curr Opin Hematol; 2008 Jan; 15(1):30-6. PubMed ID: 18043243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.